Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059606) titled 'Epidemiological study of epNEC and LCNEC-L patients in Japan using the MASTER KEY Registry' on Oct. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Nippon Boehringer Ingelheim Co., Ltd.
Condition:
Condition - extra-pulmonary neuroendocrine carcinoma (epNEC) and large cell neuroendocrine carcinoma of the lung (LCNEC-L)
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - Among patients with epNEC and LCNEC-L in the MASTER KEY Registry Database, to describe:
A) Patient demographics, clinical characteristics and biomarkers
B) Treatment status at each line...